PROFESSIONAL EDITION

The largest community of pharma leaders

Look Who’s On the Move!

      GenEdit Expands Leadership Team to Advance Targeted Genetic Medicines into Clinical Trials

      SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--GenEdit, Inc., a biotechnology company with a mission to develop curative therapies through targeted in vivo delivery of genetic medicines,...

      Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Two New Board Members

      REDWOOD CITY, Calif. & NEW YORK--(BUSINESS WIRE)--Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, and Amplitude Healthcare Acquisition Corporation (Nasdaq:...

      Sage Therapeutics Appoints Chris Benecchi as Chief Commercial Officer

      CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with...

      Aerie Pharmaceuticals, Inc. Announces the Appointment of Interim Executive Chair and Departure of Chairman and CEO

      DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company, today announced that it is executing its succession plan for its long-serving Chairman...

      ReForm Biologics Bolsters Diversity With New Appointments to Board of Directors

      WOBURN, Mass.--(BUSINESS WIRE)--ReForm Biologics, Inc., a company developing a new generation of innovative biologic medicines to improve patient access, safety, and convenience, today announced...

      Be Bio Appoints Mitchell Chan as Chief Financial Officer & Head of Corporate Strategy

      CAMBRIDGE, Mass.--(BUSINESS WIRE)--Be Biopharma (“Be Bio”), whose mission is to pioneer the emerging new class of engineered B cells as medicines, today announced that...

      Recent Articles